An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen
NCT00917514 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2010-02-26
Summary
This is a study of the electronical dosing tool MedicPen and it's qualities with regards to user friendliness and medication compliance.
Conditions
Sponsors & Collaborators
-
Medicpen AB
lead INDUSTRY
Principal Investigators
-
Mikael Lördal, Cheif MD · Department for Gastrointestinal Medicine, Karolinska University Hospital, Huddinge
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2010-02-28
- Completion
- 2010-02-28
Countries
- Sweden
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Severely Active Crohn's Disease (UNITI-2)
NCT01369342 ·Status: COMPLETED ·Phase: PHASE3
-
Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine
NCT00946946 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
NCT05599347 ·Status: RECRUITING ·Phase: PHASE2
-
Study Evaluating rhIL-11 in Active Crohn's Disease
NCT00040521 ·Status: COMPLETED ·Phase: PHASE2
-
Wireless Capsule Endoscopy in Small-Bowel Crohn's Disease
NCT00178438 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
NCT01203631 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease
NCT00487396 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
NCT01714726 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of FFP104 in Subjects With Crohn's Disease
NCT02465944 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis
NCT03169894 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
NCT03782376 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease
NCT04173273 ·Status: TERMINATED ·Phase: PHASE3
-
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
NCT00655733 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.
NCT03241368 ·Status: COMPLETED ·Phase: NA
-
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)
NCT01369355 ·Status: COMPLETED ·Phase: PHASE3
-
Confirmatory Clinical Study in Active Ulcerative Colitis
NCT07296315 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
NCT01369329 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis
NCT03358706 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy
NCT00771667 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease
NCT01751152 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Abatacept in Patients With Active Crohn's Disease
NCT00406653 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
NCT04673357 ·Status: COMPLETED ·Phase: PHASE3
-
Study for the Treatment of Crohn's Disease With Adacolumn
NCT00162942 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
NCT06882993 ·Status: RECRUITING ·Phase: NA